Hualan Biological Bacterin Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 149.01 million compared to CNY 1,058.39 million a year ago. Revenue was CNY 149.6 million compared to CNY 1,060.56 million a year ago.

Net income was CNY 108.22 million compared to CNY 298.19 million a year ago. Basic earnings per share from continuing operations was CNY 0.1804 compared to CNY 0.5141 a year ago. Diluted earnings per share from continuing operations was CNY 0.1804 compared to CNY 0.5141 a year ago.